Skip to main content

Advertisement

Log in

The Role of Host Genetics in the Susceptibility for HIV-associated Neurocognitive Disorders

  • Original Paper
  • Published:
AIDS and Behavior Aims and scope Submit manuscript

Abstract

Despite progress in the treatment of the Human Immunodeficiency virus (HIV), there continues to be a high prevalence of infected individuals who develop neurocognitive deficits and disorders. Our understanding of the potential cause of HIV-associated neurocognitive disorders (HAND) continues to develop on many fronts. Among them is the study of host genetics. Here, we review the most current information regarding the association between host genetics and risk for HIV infection, AIDS, and HAND. We focus on the role of dopamine dysfunction in the etiology of HAND, and propose a number of genetic polymorphisms within genes related to dopaminergic functioning and other neurobiological factors that may confer vulnerability or protection against HAND.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

HIV:

Human immunodeficiency virus

HAND:

HIV-associated neurocognitive disorders

AIDS:

Acquired immunodeficiency syndrome

HACMC:

HIV-1-associated cognitive/motor complex

MCMD:

HIV-1-associated minor cognitive/motor disorder

HAD:

HIV-associated dementia

CNS:

Central nervous system

CCR:

Chemokine receptor

MCP-1:

Monocyte chemo attractant protein-1

HIVE:

HIV encephalitis

TNF:

Tumor necrosis factor

IL:

Interleukin

MRI:

Magnetic resonance imaging

fMRI:

Functional magnetic resonance imaging

MRS:

Magnetic resonance spectroscopy

PET:

Positron emission tomography

DA:

Dopamine

DAT1:

Dopamine transporter

DRD:

Dopamine receptor

CSF:

Cerebrospinal fluid

HAART:

Highly active antiretroviral therapy

GP:

Genetic polymorphism

mRNA:

Messenger ribonucleic acid

SDF-1:

Stromal cell-derived factor-1

RANTES:

Regulated upon Activation, Normal T-cell Expressed, and Secreted

COMT:

Catechol-O-methyltransferase

VNTR:

Variable nucleotide tandem repeat

ADHD:

Attention deficit/hyperactivity disorder

DBH:

Dopamine-beta-hydroxylase

BNDF:

Brain derived neurotrophic factor

ApoE:

Apolipoprotein E

DARPP-32:

Dopamine and cAMP-regulated phosphoprotein of molecular weight 32 kDa

NNTC:

National NeuroAIDS Tissue Consortium

MACS:

Multicenter AIDS Cohort Study

References

  • Abraham, S., Sweet, T., Sawaya, B. E., Rappaport, J., Khalili, K., & Amini, S. (2005). Cooperative interaction of C/EBP beta and Tat modulates MCP-1 gene transcription in astrocytes. Journal of Neuroimmunology, 160(1–2), 219–227.

    PubMed  CAS  Google Scholar 

  • Agace, W. W., Amara, A., Roberts, A. I., Pablos, J. L., Thelen, S., Uguccioni, M., Li, X. Y., Marsal, J., Arenzana-Seisdedos, F., Delaunay, T., Ebert, E. C., Moser, B., & Parker, C. M. (2000). Constitutive expression of stromal derived factor-1 by mucosal epithelia and its role in HIV transmission and propagation. Current Biology, 10(6), 325–328.

    PubMed  CAS  Google Scholar 

  • Ances, B. M., & Ellis, R. J. (2007). Dementia and neurocognitive disorders due to HIV-1 infection. Seminars in Neurology, 27(1), 86–92.

    PubMed  Google Scholar 

  • Anderson, E., Zink, W., Xiong, H., & Gendelman, H. E. (2002). HIV-1-associated dementia: A metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes. Journal of Acquired Immune Deficiency Syndrome, 31(Suppl 2), S43–54.

    CAS  Google Scholar 

  • Antinori, A., Arendt, G., Becker, J. T., Brew, B. J., Byrd, D. A., Cherner, M., Clifford, D. B., Cinque, P., Epstein, L. G., Goodkin, K., Gisslen, M., Grant, I., Heaton, R. K., Joseph, J., Marder, K., Marra, C. M., McArthur, J. C., Nunn, M., Price, R. W., Pulliam, L., Robertson, K. R., Sacktor, N., Valcour, V., & Wojna, V. E. (2007). Updated research nosology for HIV-associated neurocognitive disorders. Neurology, 69(18), 1789–1799.

    PubMed  CAS  Google Scholar 

  • Arendt, G., & von Giesen, H. J. (2002). Human immunodeficiency virus dementia: Evidence of a subcortical process from studies of fine finger movements. Journal of Neurovirology, 8(Suppl 2), 27–32.

    PubMed  Google Scholar 

  • Asensio, V. C., & Campbell, I. L. (1999). Chemokines in the CNS: Plurifunctional mediators in diverse states. Trends in Neuroscience, 22(11), 504–512.

    CAS  Google Scholar 

  • Avison, M. J., Nath, A., Greene-Avison, R., Schmitt, F. A., Bales, R. A., Ethisham, A., Greenberg, R. N., & Berger, J. R. (2004a). Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia. Journal of Neurovirology, 10(4), 223–232.

    PubMed  CAS  Google Scholar 

  • Avison, M. J., Nath, A., Greene-Avison, R., Schmitt, F. A., Greenberg, R. N., & Berger, J. R. (2004b). Neuroimaging correlates of HIV-associated BBB compromise. Journal of Neuroimmunology, 157(1–2), 140–146.

    PubMed  CAS  Google Scholar 

  • Aylward, E. H., Henderer, J. D., McArthur, J. C., Brettschneider, P. D., Harris, G. J., Barta, P. E., & Pearlson, G. D. (1993). Reduced basal ganglia volume in HIV-1-associated dementia: Results from quantitative neuroimaging. Neurology, 43(10), 2099–2104.

    PubMed  CAS  Google Scholar 

  • Becker, J. T., Lopez, O. L., Dew, M. A., & Aizenstein, H. J. (2004). Prevalence of cognitive disorders differs as a function of age in HIV virus infection. AIDS, 18(Suppl 1), S11–18.

    PubMed  Google Scholar 

  • Bell, J. E. (2004). An update on the neuropathology of HIV in the HAART era. Histopathology, 45(6), 549–559.

    PubMed  CAS  Google Scholar 

  • Benjamin, J., Li, L., Patterson, C., Greenberg, B. D., Murphy, D. L., & Hamer, D. H. (1996). Population and familial association between the D4 dopamine receptor gene and measures of Novelty Seeking. Nature Genetics, 12(1), 81–84.

    PubMed  CAS  Google Scholar 

  • Bennett, B. A., Rusyniak, D. E., & Hollingsworth, C. K. (1995). HIV-1 gp120-induced neurotoxicity to midbrain dopamine cultures. Brain Research, 705(1–2), 168–176.

    PubMed  CAS  Google Scholar 

  • Benos, D. J., McPherson, S., Hahn, B. H., Chaikin, M. A., & Benveniste, E. N. (1994). Cytokines and HIV envelope glycoprotein gp120 stimulate Na+/H+ exchange in astrocytes. Journal of Biological Chemistry, 269(19), 13811–13816.

    PubMed  CAS  Google Scholar 

  • Berger, J. R., Kumar, M., Kumar, A., Fernandez, J. B., & Levin, B. (1994). Cerebrospinal fluid dopamine in HIV-1 infection. AIDS, 8(1), 67–71.

    PubMed  CAS  Google Scholar 

  • Berger, J. R., & Nath, A. (1997). HIV dementia and the basal ganglia. Intervirology, 40(2–3), 122–131.

    Article  PubMed  CAS  Google Scholar 

  • Berger, J. R., Nath, A., Greenberg, R. N., Andersen, A. H., Greene, R. A., Bognar, A., & Avison, M. J. (2000). Cerebrovascular changes in the basal ganglia with HIV dementia. Neurology, 54(4), 921–926.

    PubMed  CAS  Google Scholar 

  • Bertolino, A., Blasi, G., Latorre, V., Rubino, V., Rampino, A., Sinibaldi, L., Caforio, G., Petruzzella, V., Pizzuti, A., Scarabino, T., Nardini, M., Weinberger, D. R., & Dallapiccola, B. (2006). Additive effects of genetic variation in dopamine regulating genes on working memory cortical activity in human brain. Journal of Neuroscience, 26(15), 3918–3922.

    PubMed  CAS  Google Scholar 

  • Bilder, R. M., Volavka, J., Czobor, P., Malhotra, A. K., Kennedy, J. L., Ni, X., Goldman, R. S., Hoptman, M. J., Sheitman, B., Lindenmayer, J. P., Citrome, L., McEvoy, J. P., Kunz, M., Chakos, M., Cooper, T. B., & Lieberman, J. A. (2002). Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biological Psychiatry, 52(7), 701–707.

    PubMed  CAS  Google Scholar 

  • Bornstein, R. A., Nasrallah, H. A., Para, M. F., Whitacre, C. C., Rosenberger, P., & Fass, R. J. (1993). Neuropsychological performance in symptomatic and asymptomatic HIV infection. AIDS, 7(4), 519–524.

    PubMed  CAS  Google Scholar 

  • Boven, L. A., van der Bruggen, T., van Asbeck, B. S., Marx, J. J., & Nottet, H. S. (1999). Potential role of CCR5 polymorphism in the development of AIDS dementia complex. FEMS Immunology and Medical Microbiology, 26(3–4), 243–247.

    PubMed  CAS  Google Scholar 

  • Brabers, N. A., & Nottet, H. S. (2006). Role of the pro-inflammatory cytokines TNF-alpha and IL-1beta in HIV-associated dementia. European Journal of Clinical Investigation, 36(7), 447–458.

    PubMed  CAS  Google Scholar 

  • Cartier, L., Hartley, O., Dubois-Dauphin, M., & Krause, K. H. (2005). Chemokine receptors in the central nervous system: Role in brain inflammation and neurodegenerative diseases. Brain Research. Brain Research Reviews, 48(1), 16–42.

    PubMed  CAS  Google Scholar 

  • Chang, L., Tomasi, D., Yakupov, R., Lozar, C., Arnold, S., Caparelli, E., & Ernst, T. (2004). Adaptation of the attention network in human immunodeficiency virus brain injury. Annals of Neurology, 56(2), 259–272.

    PubMed  Google Scholar 

  • Chao, C. C., & Hu, S. (1994). Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures. Developmental Neuroscience, 16(3–4), 172–179.

    PubMed  CAS  Google Scholar 

  • Cherner, M., Ellis, R. J., Lazzaretto, D., Young, C., Mindt, M. R., Atkinson, J. H., Grant, I., & Heaton, R. K. (2004). Effects of HIV-1 infection and aging on neurobehavioral functioning: Preliminary findings. AIDS, 18(Suppl 1), S27–34.

    PubMed  Google Scholar 

  • Cherner, M., Letendre, S., Heaton, R. K., Durelle, J., Marquie-Beck, J., Gragg, B., & Grant, I. (2005). Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology, 64(8), 1343–1347.

    PubMed  CAS  Google Scholar 

  • Cherner, M., Masliah, E., Ellis, R. J., Marcotte, T. D., Moore, D. J., Grant, I., & Heaton, R. K. (2002). Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis. Neurology, 59(10), 1563–1567.

    PubMed  CAS  Google Scholar 

  • Clements, J. E., Li, M., Gama, L., Bullock, B., Carruth, L. M., Mankowski, J. L., & Zink, M. C. (2005). The central nervous system is a viral reservoir in simian immunodeficiency virus-infected macaques on combined antiretroviral therapy: A model for human immunodeficiency virus patients on highly active antiretroviral therapy. Journal of Neurovirology, 11(2), 180–189.

    PubMed  CAS  Google Scholar 

  • Cocchi, F., DeVico, A. L., Garzino-Demo, A., Arya, S. K., Gallo, R. C., & Lusso, P. (1995). Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science, 270(5243), 1811–1815.

    PubMed  CAS  Google Scholar 

  • Corder, E. H., Robertson, K., Lannfelt, L., Bogdanovic, N., Eggertsen, G., Wilkins, J., & Hall, C. (1998). HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nature Medicine, 4(10), 1182–1184.

    PubMed  CAS  Google Scholar 

  • Cysique, L. A., Maruff, P., & Brew, B. J. (2004). Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: A combined study of two cohorts. Journal of Neurovirology, 10(6), 350–357.

    PubMed  Google Scholar 

  • D’Hooge, R., Franck, F., Mucke, L., & De Deyn, P. P. (1999). Age-related behavioural deficits in transgenic mice expressing the HIV-1 coat protein gp120. European Journal of Neuroscience, 11(12), 4398–4402.

    PubMed  CAS  Google Scholar 

  • Dal Pan, G. J., McArthur, J. H., Aylward, E., Selnes, O. A., Nance-Sproson, T. E., Kumar, A. J., Mellits, E. D., & McArthur, J. C. (1992). Patterns of cerebral atrophy in HIV-1-infected individuals: Results of a quantitative MRI analysis. Neurology, 42(11), 2125–2130.

    PubMed  CAS  Google Scholar 

  • Daly, G., Hawi, Z., Fitzgerald, M., & Gill, M. (1999). Mapping susceptibility loci in attention deficit hyperactivity disorder: Preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Molecular Psychiatry, 4(2), 192–196.

    PubMed  CAS  Google Scholar 

  • Diaz-Arrastia, R., Gong, Y., Kelly, C. J., & Gelman, B. B. (2004). Host genetic polymorphisms in human immunodeficiency virus-related neurologic disease. Journal of Neurovirology, 10(Suppl 1), 67–73.

    PubMed  CAS  Google Scholar 

  • Do, H., Vasilescu, A., Carpentier, W., Meyer, L., Diop, G., Hirtzig, T., Coulonges, C., Labib, T., Spadoni, J. L., Therwath, A., Lathrop, M., Matsuda, F., & Zagury, J. F. (2006). Exhaustive genotyping of the interleukin-1 family genes and associations with AIDS progression in a French cohort. Journal of Infectious Diseases, 194(11), 1492–1504.

    PubMed  CAS  Google Scholar 

  • Dore, G. J., McDonald, A., Li, Y., Kaldor, J. M., & Brew, B. J. (2003). Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS, 17(10), 1539–1545.

    PubMed  Google Scholar 

  • Dragic, T., Litwin, V., Allaway, G. P., Martin, S. R., Huang, Y., Nagashima, K. A., Cayanan, C., Maddon, P. J., Koup, R. A., Moore, J. P., & Paxton, W. A. (1996). HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature, 381(6584), 667–673.

    PubMed  CAS  Google Scholar 

  • Edelstein, H., & Knight, R. T. (1987). Severe parkinsonism in two AIDS patients taking prochlorperazine. Lancet, 2(8554), 341–342.

    PubMed  CAS  Google Scholar 

  • Egan, M. F., Goldberg, T. E., Kolachana, B. S., Callicott, J. H., Mazzanti, C. M., Straub, R. E., Goldman, D., & Weinberger, D. R. (2001). Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proceedings of the National Academy of Sciences of the United States of America, 98(12), 6917–6922.

    PubMed  CAS  Google Scholar 

  • Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., Lu, B., & Weinberger, D. R. (2003). The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell, 112(2), 257–269.

    PubMed  CAS  Google Scholar 

  • El-Hage, N., Wu, G., Wang, J., Ambati, J., Knapp, P. E., Reed, J. L., Bruce-Keller, A. J., & Hauser, K. F. (2006). HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines. Glia, 53(2), 132–146.

    PubMed  Google Scholar 

  • Engelmayer, J., Larsson, M., Lee, A., Lee, M., Cox, W. I., Steinman, R. M., & Bhardwaj, N. (2001). Mature dendritic cells infected with canarypox virus elicit strong anti-human immunodeficiency virus CD8+ and CD4+ T-cell responses from chronically infected individuals. Journal of Virology, 75(5), 2142–2153.

    PubMed  CAS  Google Scholar 

  • Ernst, T., Chang, L., Leonido-Yee, M., & Speck, O. (2000). Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study. Neurology, 54(6), 1344–1349.

    PubMed  CAS  Google Scholar 

  • Falangola, M. F., Hanly, A., Galvao-Castro, B., & Petito, C. K. (1995). HIV infection of human choroid plexus: A possible mechanism of viral entry into the CNS. Journal of Neuropathology and Experimental Neurology, 54(4), 497–503.

    PubMed  CAS  Google Scholar 

  • Fellay, J., Shianna, K. V., Ge, D., Colombo, S., Ledergerber, B., Weale, M., Zhang, K., Gumbs, C., Castagna, A., Cossarizza, A., Cozzi-Lepri, A., De Luca, A., Easterbrook, P., Francioli, P., Mallal, S., Martinez-Picado, J., Miro, J. M., Obel, N., Smith, J. P., Wyniger, J., Descombes, P., Antonarakis, S. E., Letvin, N. L., McMichael, A. J., Haynes, B. F., Telenti, A., & Goldstein, D. B. (2007). A whole-genome association study of major determinants for host control of HIV-1. Science, 317(5840), 944–947.

    PubMed  CAS  Google Scholar 

  • Freimer, N. B., & Sabatti, C. (2007). Human genetics: Variants in common diseases. Nature, 445(7130), 828–830.

    PubMed  CAS  Google Scholar 

  • Galea, I., Bechmann, I., & Perry, V. H. (2007). What is immune privilege (not)? Trends in Immunology, 28(1), 12–18.

    PubMed  CAS  Google Scholar 

  • Gartner, S. (2000). HIV infection and dementia. Science, 287(5453), 602–604.

    PubMed  CAS  Google Scholar 

  • Gelbard, H. A., Nottet, H. S., Swindells, S., Jett, M., Dzenko, K. A., Genis, P., White, R., Wang, L., Choi, Y. B., & Zhang, D., et al. (1994). Platelet-activating factor: A candidate human immunodeficiency virus type 1-induced neurotoxin. Journal of Virology, 68(7), 4628–4635.

    PubMed  CAS  Google Scholar 

  • Gendelman, H. E., Orenstein, J. M., Baca, L. M., Weiser, B., Burger, H., Kalter, D. C., & Meltzer, M. S. (1989). The macrophage in the persistence and pathogenesis of HIV infection. AIDS, 3(8), 475–495.

    Article  PubMed  CAS  Google Scholar 

  • Goldberg, T. E., Egan, M. F., Gscheidle, T., Coppola, R., Weickert, T., Kolachana, B. S., Goldman, D., & Weinberger, D. R. (2003). Executive subprocesses in working memory: Relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Archives of General Psychiatry, 60(9), 889–896.

    PubMed  CAS  Google Scholar 

  • Gonzalez, E., Dhanda, R., Bamshad, M., Mummidi, S., Geevarghese, R., Catano, G., Anderson, S. A., Walter, E. A., Stephan, K. T., Hammer, M. F., Mangano, A., Sen, L., Clark, R. A., Ahuja, S. S., Dolan, M. J., & Ahuja, S. K. (2001). Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: Impact on the epidemiology of the HIV-1 pandemic. Proceedings of the National Academy of Sciences of the United States of America, 98(9), 5199–5204.

    PubMed  CAS  Google Scholar 

  • Gonzalez, E., Rovin, B. H., Sen, L., Cooke, G., Dhanda, R., Mummidi, S., Kulkarni, H., Bamshad, M. J., Telles, V., Anderson, S. A., Walter, E. A., Stephan, K. T., Deucher, M., Mangano, A., Bologna, R., Ahuja, S. S., Dolan, M. J., & Ahuja, S. K. (2002). HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proceedings of the National Academy of Sciences of the United States of America, 99(21), 13795–13800.

    PubMed  CAS  Google Scholar 

  • Goplen, A. K., Liestol, K., Dunlop, O., Bruun, J. N., & Maehlen, J. (2001). Dementia in AIDS patients in Oslo; the role of HIV encephalitis and CMV encephalitis. Scandinavian Journal of Infectious Diseases, 33(10), 755–758.

    PubMed  CAS  Google Scholar 

  • Gray, F., Chretien, F., Vallat-Decouvelaere, A. V., & Scaravilli, F. (2003). The changing pattern of HIV neuropathology in the HAART era. Journal of Neuropathology and Experimental Neurology, 62(5), 429–440.

    PubMed  Google Scholar 

  • Guillin, O., Diaz, J., Carroll, P., Griffon, N., Schwartz, J. C., & Sokoloff, P. (2001). BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature, 411(6833), 86–89.

    PubMed  CAS  Google Scholar 

  • Hariri, A. R., Goldberg, T. E., Mattay, V. S., Kolachana, B. S., Callicott, J. H., Egan, M. F., & Weinberger, D. R. (2003). Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. Journal of Neuroscience, 23(17), 6690–6694.

    PubMed  CAS  Google Scholar 

  • He, J., Chen, Y., Farzan, M., Choe, H., Ohagen, A., Gartner, S., Busciglio, J., Yang, X., Hofmann, W., Newman, W., Mackay, C. R., Sodroski, J., & Gabuzda, D. (1997). CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature, 385(6617), 645–649.

    PubMed  CAS  Google Scholar 

  • Hesselgesser, J., Taub, D., Baskar, P., Greenberg, M., Hoxie, J., Kolson, D. L., & Horuk, R. (1998). Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 alpha is mediated by the chemokine receptor CXCR4. Current Biology, 8(10), 595–598.

    PubMed  CAS  Google Scholar 

  • Hinkin, C. H., van Gorp, W. G., Mandelkern, M. A., Gee, M., Satz, P., Holston, S., Marcotte, T. D., Evans, G., Paz, D. H., & Ropchan, J. R., et al. (1995). Cerebral metabolic change in patients with AIDS: Report of a six-month follow-up using positron-emission tomography. Journal of Neuropsychiatry and Clinical Neurosciences, 7(2), 180–187.

    PubMed  CAS  Google Scholar 

  • Hirvonen, M., Laakso, A., Nagren, K., Rinne, J. O., Pohjalainen, T., & Hietala, J. (2004). C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo. Molecular Psychiatry, 9(12), 1060–1061.

    PubMed  CAS  Google Scholar 

  • Itoh, K., Mehraein, P., & Weis, S. (2000). Neuronal damage of the substantia nigra in HIV-1 infected brains. Acta Neuropathological (Berlin), 99(4), 376–384.

    CAS  Google Scholar 

  • Jacobsen, L. K., Giedd, J. N., Gottschalk, C., Kosten, T. R., & Krystal, J. H. (2001). Quantitative morphology of the caudate and putamen in patients with cocaine dependence. American Journal of Psychiatry, 158(3), 486–489.

    PubMed  CAS  Google Scholar 

  • Jones, M., Olafson, K., Del Bigio, M. R., Peeling, J., & Nath, A. (1998). Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement. Journal of Neuropathology and Experimental Neurology, 57(6), 563–570.

    PubMed  CAS  Google Scholar 

  • Kaul, M., & Lipton, S. A. (1999). Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proceedings of the National Academy of Sciences of the United States of America, 96(14), 8212–8216.

    PubMed  CAS  Google Scholar 

  • Kaul, M., Zheng, J., Okamoto, S., Gendelman, H. E., & Lipton, S. A. (2005). HIV-1 infection and AIDS: Consequences for the central nervous system. Cell Death and Differentiation, 12(Suppl 1), 878–892.

    PubMed  CAS  Google Scholar 

  • Kieburtz, K. D., Epstein, L. G., Gelbard, H. A., & Greenamyre, J. T. (1991). Excitotoxicity and dopaminergic dysfunction in the acquired immunodeficiency syndrome dementia complex. Therapeutic implications. Archives of Neurology, 48(12), 1281–1284.

    PubMed  CAS  Google Scholar 

  • Koutsilieri, E., Sopper, S., Scheller, C., ter Meulen, V., & Riederer, P. (2002). Parkinsonism in HIV dementia. Journal of Neural Transmission, 109(5–6), 767–775.

    PubMed  CAS  Google Scholar 

  • Kramer-Hammerle, S., Rothenaigner, I., Wolff, H., Bell, J. E., & Brack-Werner, R. (2005). Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus. Virus Research, 111(2), 194–213.

    PubMed  Google Scholar 

  • Lachman, H. M., Papolos, D. F., Saito, T., Yu, Y. M., Szumlanski, C. L., & Weinshilboum, R. M. (1996). Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics, 6(3), 243–250.

    PubMed  CAS  Google Scholar 

  • Langford, T. D., Letendre, S. L., Larrea, G. J., & Masliah, E. (2003). Changing patterns in the neuropathogenesis of HIV during the HAART era. Brain Pathology, 13(2), 195–210.

    Article  PubMed  CAS  Google Scholar 

  • Larsson, M., Hagberg, L., Forsman, A., & Norkrans, G. (1991). Cerebrospinal fluid catecholamine metabolites in HIV-infected patients. Journal of Neuroscience Research, 28(3), 406–409.

    PubMed  CAS  Google Scholar 

  • Levine, A. J., Hardy, D. J., Miller, E., Castellon, S. A., Longshore, D., & Hinkin, C. H. (2006). The effect of recent stimulant use on sustained attention in HIV-infected adults. Journal of Clinical and Experimental Neuropsychology, 28(1), 29–42.

    PubMed  Google Scholar 

  • Li, T., Chen, C. K., Hu, X., Ball, D., Lin, S. K., Chen, W., Sham, P. C., Loh el, W., Murray, R. M., & Collier, D. A. (2004). Association analysis of the DRD4 and COMT genes in methamphetamine abuse. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 129(1), 120–124.

    Google Scholar 

  • Lichter, J. B., Barr, C. L., Kennedy, J. L., Van Tol, H. H., Kidd, K. K., & Livak, K. J. (1993). A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. Human Molecular Genetics, 2(6), 767–773.

    PubMed  CAS  Google Scholar 

  • Little, K. Y., Zhang, L., Desmond, T., Frey, K. A., Dalack, G. W., & Cassin, B. J. (1999). Striatal dopaminergic abnormalities in human cocaine users. American Journal of Psychiatry, 156(2), 238–245.

    PubMed  CAS  Google Scholar 

  • Liu, H., Chao, D., Nakayama, E. E., Taguchi, H., Goto, M., Xin, X., Takamatsu, J. K., Saito, H., Ishikawa, Y., Akaza, T., Juji, T., Takebe, Y., Ohishi, T., Fukutake, K., Maruyama, Y., Yashiki, S., Sonoda, S., Nakamura, T., Nagai, Y., Iwamoto, A., & Shioda, T. (1999). Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proceedings of the National Academy of Sciences of the United States of America, 96(8), 4581–4585.

    PubMed  CAS  Google Scholar 

  • Malhotra, A. K., Kestler, L. J., Mazzanti, C., Bates, J. A., Goldberg, T., & Goldman, D. (2002). A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. American Journal of Psychiatry, 159(4), 652–654.

    PubMed  Google Scholar 

  • Maslin, C. L., Kedzierska, K., Webster, N. L., Muller, W. A., & Crowe, S. M. (2005). Transendothelial migration of monocytes: The underlying molecular mechanisms and consequences of HIV-1 infection. Current HIV Research, 3(4), 303–317.

    PubMed  CAS  Google Scholar 

  • Mattay, V. S., Goldberg, T. E., Fera, F., Hariri, A. R., Tessitore, A., Egan, M. F., Kolachana, B., Callicott, J. H., & Weinberger, D. R. (2003). Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proceedings of the National Academy of Sciences of the United States of America, 100(10), 6186–6191.

    PubMed  CAS  Google Scholar 

  • Mattson, M. P., Haughey, N. J., & Nath, A. (2005). Cell death in HIV dementia. Cell Death and Differentiation, 12(Suppl 1), 893–904.

    PubMed  CAS  Google Scholar 

  • McDermott, D. H., Beecroft, M. J., Kleeberger, C. A., Al-Sharif, F. M., Ollier, W. E., Zimmerman, P. A., Boatin, B. A., Leitman, S. F., Detels, R., Hajeer, A. H., & Murphy, P. M. (2000). Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study. AIDS, 14(17), 2671–2678.

    PubMed  CAS  Google Scholar 

  • Meucci, O., Fatatis, A., Simen, A. A., Bushell, T. J., Gray, P. W., & Miller, R. J. (1998). Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proceedings of the National Academy of Sciences of the United States of America, 95(24), 14500–14505.

    PubMed  CAS  Google Scholar 

  • Meyer-Lindenberg, A., Straub, R. E., Lipska, B. K., Verchinski, B. A., Goldberg, T., Callicott, J. H., Egan, M. F., Huffaker, S. S., Mattay, V. S., Kolachana, B., Kleinman, J. E., & Weinberger, D. R. (2007). Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition. Journal of Clinical Investigation, 117(3), 672–682.

    PubMed  CAS  Google Scholar 

  • Meyer, L., Magierowska, M., Hubert, J. B., Rouzioux, C., Deveau, C., Sanson, F., Debre, P., Delfraissy, J. F., & Theodorou, I. (1997). Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: Relationship with viral load. The SEROCO Study Group. AIDS, 11(11), F73–78.

    PubMed  CAS  Google Scholar 

  • Michael, N. L., & Moore, J. P. (1999). HIV-1 entry inhibitors: Evading the issue. Nature Medicine, 5(7), 740–742.

    PubMed  CAS  Google Scholar 

  • Mill, J., Fisher, N., Curran, S., Richards, S., Taylor, E., & Asherson, P. (2003). Polymorphisms in the dopamine D4 receptor gene and attention-deficit hyperactivity disorder. Neuroreport, 14(11), 1463–1466.

    PubMed  CAS  Google Scholar 

  • Mossner, R., Daniel, S., Albert, D., Heils, A., Okladnova, O., Schmitt, A., & Lesch, K. P. (2000). Serotonin transporter function is modulated by brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF). Neurochemistry International, 36(3), 197–202.

    PubMed  CAS  Google Scholar 

  • Nath, A., & Geiger, J. (1998). Neurobiological aspects of human immunodeficiency virus infection: Neurotoxic mechanisms. Progress in Neurobiology, 54(1), 19–33.

    PubMed  CAS  Google Scholar 

  • Nath, A., Haughey, N. J., Jones, M., Anderson, C., Bell, J. E., & Geiger, J. D. (2000). Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: Protection by memantine. Annals of Neurology, 47(2), 186–194.

    PubMed  CAS  Google Scholar 

  • Nath, A., Maragos, W. F., Avison, M. J., Schmitt, F. A., & Berger, J. R. (2001). Acceleration of HIV dementia with methamphetamine and cocaine. Journal of Neurovirology, 7(1), 66–71.

    PubMed  CAS  Google Scholar 

  • Navia, B. A., Jordan, B. D., & Price, R. W. (1986). The AIDS dementia complex: I. Clinical features. Annals of Neurology, 19(6), 517–524.

    PubMed  CAS  Google Scholar 

  • Navia, B. A., & Price, R. W. (1987). The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus infection. Archives of Neurology, 44(1), 65–69.

    PubMed  CAS  Google Scholar 

  • Neuenburg, J. K., Brodt, H. R., Herndier, B. G., Bickel, M., Bacchetti, P., Price, R. W., Grant, R. M., & Schlote, W. (2002). HIV-related neuropathology, 1985 to 1999: Rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndrome, 31(2), 171–177.

    Google Scholar 

  • Nolan, K. A., Bilder, R. M., Lachman, H. M., & Volavka, J. (2004). Catechol O-methyltransferase Val158Met polymorphism in schizophrenia: Differential effects of Val and Met alleles on cognitive stability and flexibility. American Journal of Psychiatry, 161(2), 359–361.

    PubMed  Google Scholar 

  • Nosheny, R. L., Mocchetti, I., & Bachis, A. (2005). Brain-derived neurotrophic factor as a prototype neuroprotective factor against HIV-1-associated neuronal degeneration. Neurotoxicology Research, 8(1–2), 187–198.

    Article  CAS  Google Scholar 

  • Ouimet, C. C., LaMantia, A. S., Goldman-Rakic, P., Rakic, P., & Greengard, P. (1992). Immunocytochemical localization of DARPP-32, a dopamine and cyclic-AMP-regulated phosphoprotein, in the primate brain. Journal of Comparative Neurology, 323(2), 209–218.

    PubMed  CAS  Google Scholar 

  • Palmer, D. L., Hjelle, B. L., Wiley, C. A., Allen, S., Wachsman, W., Mills, R. G., Davis, L. E., & Merlin, T. L. (1994). HIV-1 infection despite immediate combination antiviral therapy after infusion of contaminated white cells. American Journal of Medicine, 97(3), 289–295.

    PubMed  CAS  Google Scholar 

  • Peng, H., Erdmann, N., Whitney, N., Dou, H., Gorantla, S., Gendelman, H. E., Ghorpade, A., & Zheng, J. (2006). HIV-1-infected and/or immune activated macrophages regulate astrocyte SDF-1 production through IL-1beta. Glia, 54(6), 619–629.

    PubMed  Google Scholar 

  • Persidsky, Y., & Gendelman, H. E. (2003). Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection. Journal of Leukocyte Biology, 74(5), 691–701.

    PubMed  CAS  Google Scholar 

  • Persidsky, Y., & Poluektova, L. (2006). Immune privilege and HIV-1 persistence in the CNS. Immunology Review, 213, 180–194.

    CAS  Google Scholar 

  • Persidsky, Y., Stins, M., Way, D., Witte, M. H., Weinand, M., Kim, K. S., Bock, P., Gendelman, H. E., & Fiala, M. (1997). A model for monocyte migration through the blood–brain barrier during HIV-1 encephalitis. Journal of Immunology, 158(7), 3499–3510.

    CAS  Google Scholar 

  • Persidsky, Y., Zheng, J., Miller, D., & Gendelman, H. E. (2000). Mononuclear phagocytes mediate blood–brain barrier compromise and neuronal injury during HIV-1-associated dementia. Journal of Leukocyte Biology, 68(3), 413–422.

    PubMed  CAS  Google Scholar 

  • Petito, C. K. (2004). Human immunodeficiency virus type 1 compartmentalization in the central nervous system. Journal of Neurovirology, 10(Suppl 1), 21–24.

    PubMed  CAS  Google Scholar 

  • Pezawas, L., Verchinski, B. A., Mattay, V. S., Callicott, J. H., Kolachana, B. S., Straub, R. E., Egan, M. F., Meyer-Lindenberg, A., & Weinberger, D. R. (2004). The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. Journal of Neuroscience, 24(45), 10099–10102.

    PubMed  CAS  Google Scholar 

  • Plomin, R., DeFries, J. C., McClearn, G. E., & McGuffin, P. (2001). Behavioral genetics (4th ed.). New York: Worth Publishers.

    Google Scholar 

  • Power, C., Kong, P. A., Crawford, T. O., Wesselingh, S., Glass, J. D., McArthur, J. C., & Trapp, B. D. (1993). Cerebral white matter changes in acquired immunodeficiency syndrome dementia: Alterations of the blood–brain barrier. Annals of Neurology, 34(3), 339–350.

    PubMed  CAS  Google Scholar 

  • Price, P., James, I., Fernandez, S., & French, M. A. (2004). Alleles of the gene encoding IL-1alpha may predict control of plasma viraemia in HIV-1 patients on highly active antiretroviral therapy. AIDS, 18(11), 1495–1501.

    PubMed  CAS  Google Scholar 

  • Puissant, B., Roubinet, F., Massip, P., Sandres-Saune, K., Apoil, P. A., Abbal, M., Pasquier, C., Izopet, J., & Blancher, A. (2006). Analysis of CCR5, CCR2, CX3CR1, and SDF1 polymorphisms in HIV-positive treated patients: Impact on response to HAART and on peripheral T lymphocyte counts. AIDS Research and Human Retroviruses, 22(2), 153–162.

    PubMed  CAS  Google Scholar 

  • Quasney, M. W., Zhang, Q., Sargent, S., Mynatt, M., Glass, J., & McArthur, J. (2001). Increased frequency of the tumor necrosis factor-alpha-308 A allele in adults with human immunodeficiency virus dementia. Annals of Neurology, 50(2), 157–162.

    PubMed  CAS  Google Scholar 

  • Qureshi, A. I., Hanson, D. L., Jones, J. L., & Janssen, R. S. (1998). Estimation of the temporal probability of human immunodeficiency virus (HIV) dementia after risk stratification for HIV-infected persons. Neurology, 50(2), 392–397.

    PubMed  CAS  Google Scholar 

  • Ragin, A. B., Wu, Y., Storey, P., Cohen, B. A., Edelman, R. R., & Epstein, L. G. (2006). Monocyte chemoattractant protein-1 correlates with subcortical brain injury in HIV infection. Neurology, 66(8), 1255–1257.

    PubMed  CAS  Google Scholar 

  • Resnick, L., diMarzo-Veronese, F., Schupbach, J., Tourtellotte, W. W., Ho, D. D., Muller, F., Shapshak, P., Vogt, M., Groopman, J. E., & Markham, P. D., et al. (1985). Intra-blood–brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex. New England Journal of Medicine, 313(24), 1498–1504.

    Article  PubMed  CAS  Google Scholar 

  • Rippeth, J. D., Heaton, R. K., Carey, C. L., Marcotte, T. D., Moore, D. J., Gonzalez, R., Wolfson, T., & Grant, I. (2004). Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. Journal of the International Neuropsychological Society, 10(1), 1–14.

    PubMed  CAS  Google Scholar 

  • Rogers, G., Joyce, P., Mulder, R., Sellman, D., Miller, A., Allington, M., Olds, R., Wells, E., & Kennedy, M. (2004). Association of a duplicated repeat polymorphism in the 5′-untranslated region of the DRD4 gene with novelty seeking. American Journal of Medical Genetics: Part B, Neuropsychiatric Genetics, 126(1), 95–98.

    Google Scholar 

  • Roman, T., Schmitz, M., Polanczyk, G. V., Eizirik, M., Rohde, L. A., & Hutz, M. H. (2002). Further evidence for the association between attention-deficit/hyperactivity disorder and the dopamine-beta-hydroxylase gene. American Journal of Medical Geneticst, 114(2), 154–158.

    Google Scholar 

  • Rosa, A., Peralta, V., Cuesta, M. J., Zarzuela, A., Serrano, F., Martinez-Larrea, A., & Fananas, L. (2004). New evidence of association between COMT gene and prefrontal neurocognitive function in healthy individuals from sibling pairs discordant for psychosis. American Journal of Psychiatry, 161(6), 1110–1112.

    PubMed  Google Scholar 

  • Rottenberg, D. A., Sidtis, J. J., Strother, S. C., Schaper, K. A., Anderson, J. R., Nelson, M. J., & Price, R. W. (1996). Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia. Journal of Nuclear Medicine, 37(7), 1133–1141.

    PubMed  CAS  Google Scholar 

  • Rovin, B. H., Lu, L., & Saxena, R. (1999). A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochemical and Biophysical Research Communications, 259(2), 344–348.

    PubMed  CAS  Google Scholar 

  • Samson, M., Libert, F., Doranz, B. J., Rucker, J., Liesnard, C., Farber, C. M., Saragosti, S., Lapoumeroulie, C., Cognaux, J., Forceille, C., Muyldermans, G., Verhofstede, C., Burtonboy, G., Georges, M., Imai, T., Rana, S., Yi, Y., Smyth, R. J., Collman, R. G., Doms, R. W., Vassart, G., & Parmentier, M. (1996). Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature, 382(6593), 722–725.

    PubMed  CAS  Google Scholar 

  • Sardar, A. M., Czudek, C., & Reynolds, G. P. (1996). Dopamine deficits in the brain: The neurochemical basis of parkinsonian symptoms in AIDS. Neuroreport, 7(4), 910–912.

    PubMed  CAS  Google Scholar 

  • Satz, P., Morgenstern, H., Miller, E. N., Selnes, O. A., McArthur, J. C., Cohen, B. A., Wesch, J., Becker, J. T., Jacobson, L., & D’Elia, L. F., et al. (1993). Low education as a possible risk factor for cognitive abnormalities in HIV-1: Findings from the multicenter AIDS Cohort Study (MACS). Journal of the Acquired Immune Deficiency Syndrome, 6(5), 503–511.

    CAS  Google Scholar 

  • Selmaj, K., & Raine, C. S. (1988). Tumor necrosis factor mediates myelin damage in organotypic cultures of nervous tissue. Annals of the New York Academy of Sciences, 540, 568–570.

    PubMed  CAS  Google Scholar 

  • Shapshak, P., Segal, D. M., Crandall, K. A., Fujimura, R. K., Zhang, B. T., Xin, K. Q., Okuda, K., Petito, C. K., Eisdorfer, C., & Goodkin, K. (1999). Independent evolution of HIV type 1 in different brain regions. AIDS Research and Human Retroviruses, 15(9), 811–820.

    PubMed  CAS  Google Scholar 

  • Shapshak, P., Yoshioka, M., Sun, N. C., & Schiller, P. C. (1992). The use of combined in situ hybridization and immunocytochemistry to identify HIV-infected cells in brain tissue. Modern Pathology, 5(6), 649–654.

    PubMed  CAS  Google Scholar 

  • Shrestha, S., Strathdee, S. A., Galai, N., Oleksyk, T., Fallin, M. D., Mehta, S., Schaid, D., Vlahov, D., O’Brien, S. J., & Smith, M. W. (2006). Behavioral risk exposure and host genetics of susceptibility to HIV-1 infection. Journal of Infectious Diseases, 193(1), 16–26.

    PubMed  CAS  Google Scholar 

  • Singh, K. K., Barroga, C. F., Hughes, M. D., Chen, J., Raskino, C., McKinney, R. E., & Spector, S. A. (2003). Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection. Journal of Infectious Diseases, 188(10), 1461–1472.

    PubMed  CAS  Google Scholar 

  • Singh, K. K., Ellis, R. J., Marquie-Beck, J., Letendre, S., Heaton, R. K., Grant, I., & Spector, S. A. (2004). CCR2 polymorphisms affect neuropsychological impairment in HIV-1-infected adults. Journal of Neuroimmunology, 157(1–2), 185–192.

    PubMed  CAS  Google Scholar 

  • Smalley, S. L., Bailey, J. N., Palmer, C. G., Cantwell, D. P., McGough, J. J., Del’Homme, M. A., Asarnow, J. R., Woodward, J. A., Ramsey, C., & Nelson, S. F. (1998). Evidence that the dopamine D4 receptor is a susceptibility gene in attention deficit hyperactivity disorder. Molecular Psychiatry, 3(5), 427–430.

    PubMed  CAS  Google Scholar 

  • Smit, T. K., Brew, B. J., Tourtellotte, W., Morgello, S., Gelman, B. B., & Saksena, N. K. (2004). Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment. Journal of Virology, 78(18), 10133–10148.

    PubMed  CAS  Google Scholar 

  • Smith, M. W., Dean, M., Carrington, M., Winkler, C., Huttley, G. A., Lomb, D. A., Goedert, J. J., O’Brien, T. R., Jacobson, L. P., Kaslow, R., Buchbinder, S., Vittinghoff, E., Vlahov, D., Hoots, K., Hilgartner, M. W., & O’Brien, S. J. (1997). Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science, 277(5328), 959–965.

    PubMed  CAS  Google Scholar 

  • Stern, Y. (2002). What is cognitive reserve? Theory and research application of the reserve concept. Journal of the International Neuropsychological Society, 8(3), 448–460.

    PubMed  Google Scholar 

  • Thapar, A., Harold, G., Rice, F., Langley, K., & O’donovan, M. (2007). The contribution of gene–environment interaction to psychopathology. Developmental Psychopathology, 19(4), 989–1004.

    Google Scholar 

  • Thomas, S. A. (2004). Anti-HIV drug distribution to the central nervous system. Current Pharmaceutical Design, 10(12), 1313–1324.

    PubMed  CAS  Google Scholar 

  • Tomasi, D., Chang, L., de Castro Caparelli, E., Telang, F., & Ernst, T. (2006). The human immunodeficiency virus reduces network capacity: Acoustic noise effect. Annals of Neurology, 59(2), 419–423.

    PubMed  Google Scholar 

  • Tozzi, V., Balestra, P., Lorenzini, P., Bellagamba, R., Galgani, S., Corpolongo, A., Vlassi, C., Larussa, D., Zaccarelli, M., Noto, P., Visco-Comandini, U., Giulianelli, M., Ippolito, G., Antinori, A., & Narciso, P. (2005). Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: Results from an urban observational cohort. Journal of Neurovirology, 11(3), 265–273.

    PubMed  Google Scholar 

  • Valcour, V., Shikuma, C., Shiramizu, B., Watters, M., Poff, P., Selnes, O. A., Grove, J., Liu, Y., Abdul-Majid, K. B., Gartner, S., & Sacktor, N. (2004). Age, apolipoprotein E4, and the risk of HIV dementia: The Hawaii aging with HIV cohort. Journal of Neuroimmunology, 157(1–2), 197–202.

    PubMed  CAS  Google Scholar 

  • Valcour, V., Shikuma, C., Shiramizu, B., Williams, A., Watters, M., Poff, P., Grove, J., Selnes, O., & Sacktor, N. (2005). Diabetes, insulin resistance, and dementia among HIV-1-infected patients. Journal of the Acquired Immune Deficiency Syndrome, 38(1), 31–36.

    Google Scholar 

  • Valcour, V., Shikuma, C., Watters, M., & Sacktor, N. (2004). Cognitive impairment in older HIV-1-seropositive individuals: Prevalence and potential mechanisms. AIDS, 18(Suppl 1), S79–86.

    PubMed  Google Scholar 

  • van Gorp, W. G., Mandelkern, M. A., Gee, M., Hinkin, C. H., Stern, C. E., Paz, D. K., Dixon, W., Evans, G., Flynn, F., Frederick, C. J., et al. (1992). Cerebral metabolic dysfunction in AIDS: Findings in a sample with and without dementia. Journal of Neuropsychiatry and Clinical Neurosciences, 4(3), 280–287.

    PubMed  Google Scholar 

  • van Rij, R. P., Portegies, P., Hallaby, T., Lange, J. M., Visser, J., de Roda Husman, A. M., van ‘t Wout, A. B., & Schuitemaker, H. (1999). Reduced prevalence of the CCR5 delta32 heterozygous genotype in human immunodeficiency virus-infected individuals with AIDS dementia complex. Journal of Infectious Diseases, 180(3), 854–857.

    PubMed  Google Scholar 

  • Vandenbergh, D. J., Persico, A. M., Hawkins, A. L., Griffin, C. A., Li, X., Jabs, E. W., & Uhl, G. R. (1992). Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics, 14(4), 1104–1106.

    PubMed  CAS  Google Scholar 

  • Volkow, N. D., Chang, L., Wang, G. J., Fowler, J. S., Leonido-Yee, M., Franceschi, D., Sedler, M. J., Gatley, S. J., Hitzemann, R., Ding, Y. S., Logan, J., Wong, C., & Miller, E. N. (2001). Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. American Journal of Psychiatry, 158(3), 377–382.

    PubMed  CAS  Google Scholar 

  • Wang, G. J., Chang, L., Volkow, N. D., Telang, F., Logan, J., Ernst, T., & Fowler, J. S. (2004). Decreased brain dopaminergic transporters in HIV-associated dementia patients. Brain, 127(Pt 11), 2452–2458.

    PubMed  Google Scholar 

  • Wei, J., Xu, H. M., Ramchand, C. N., & Hemmings, G. P. (1997). Is the polymorphic microsatellite repeat of the dopamine beta-hydroxylase gene associated with biochemical variability of the catecholamine pathway in schizophrenia? Biological Psychiatry, 41(7), 762–767.

    PubMed  CAS  Google Scholar 

  • Weissman, D., Dybul, M., Daucher, M. B., Davey, R. T., Jr., Walker, R. E., & Kovacs, J. A. (2000). Interleukin-2 up-regulates expression of the human immunodeficiency virus fusion coreceptor CCR5 by CD4+ lymphocytes in vivo. Journal of Infectious Diseases, 181(3), 933–938.

    PubMed  CAS  Google Scholar 

  • Wesselingh, S. L., Takahashi, K., Glass, J. D., McArthur, J. C., Griffin, J. W., & Griffin, D. E. (1997). Cellular localization of tumor necrosis factor mRNA in neurological tissue from HIV-infected patients by combined reverse transcriptase/polymerase chain reaction in situ hybridization and immunohistochemistry. Journal of Neuroimmunology, 74(1–2), 1–8.

    PubMed  CAS  Google Scholar 

  • Wiley, C. A., & Nelson, J. A. (1990). Human immunodeficiency virus: Infection of the nervous system. Current Topics in Microbiology and Immunology, 160, 157–172.

    PubMed  CAS  Google Scholar 

  • Wiley, C. A., Schrier, R. D., Nelson, J. A., Lampert, P. W., & Oldstone, M. B. (1986). Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proceedings of the National Academy of Sciences of the United States of America, 83(18), 7089–7093.

    PubMed  CAS  Google Scholar 

  • Winkler, C., Modi, W., Smith, M. W., Nelson, G. W., Wu, X., Carrington, M., Dean, M., Honjo, T., Tashiro, K., Yabe, D., Buchbinder, S., Vittinghoff, E., Goedert, J. J., O’Brien, T. R., Jacobson, L. P., Detels, R., Donfield, S., Willoughby, A., Gomperts, E., Vlahov, D., Phair, J., & O’Brien, S. J. (1998). Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science, 279(5349), 389–393.

    PubMed  CAS  Google Scholar 

  • Wojna, V., Skolasky, R. L., Hechavarria, R., Mayo, R., Selnes, O., McArthur, J. C., Melendez, L. M., Maldonado, E., Zorrilla, C. D., Garcia, H., Kraiselburd, E., & Nath, A. (2006). Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairment. Journal of Neurovirology, 12(5), 356–364.

    PubMed  Google Scholar 

  • Xu, H., Kellendonk, C. B., Simpson, E. H., Keilp, J. G., Bruder, G. E., Polan, H. J., Kandel, E. R., & Gilliam, T. C. (2007). DRD2 C957T polymorphism interacts with the COMT Val158Met polymorphism in human working memory ability. Schizophrenia Research, 90(1–3), 104–107.

    PubMed  Google Scholar 

  • Yeh, M. W., Kaul, M., Zheng, J., Nottet, H. S., Thylin, M., Gendelman, H. E., & Lipton, S. A. (2000). Cytokine-stimulated, but not HIV-infected, human monocyte-derived macrophages produce neurotoxic levels of l-cysteine. Journal of Immunology, 164(8), 4265–4270.

    CAS  Google Scholar 

  • Yoshioka, M., Shapshak, P., Sun, N. C., Nelson, S. J., Svenningsson, A., Tate, L. G., Pardo, V., & Resnick, L. (1992). Simultaneous detection of ferritin and HIV-1 in reactive microglia. Acta Neuropathologica (Berlin), 84(3), 297–306.

    CAS  Google Scholar 

  • Zabetian, C. P., Anderson, G. M., Buxbaum, S. G., Elston, R. C., Ichinose, H., Nagatsu, T., Kim, K. S., Kim, C. H., Malison, R. T., Gelernter, J., & Cubells, J. F. (2001). A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: Evidence for a major functional polymorphism at the DBH locus. American Journal of Human Genetics, 68(2), 515–522.

    PubMed  CAS  Google Scholar 

  • Zhang, H., Ozbay, F., Lappalainen, J., Kranzler, H. R., van Dyck, C. H., Charney, D. S., Price, L. H., Southwick, S., Yang, B. Z., Rasmussen, A., & Gelernter, J. (2006). Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer’s disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence. American Journal of Medical Genetics: Part B, Neuropsychiatric Genetics, 141(4), 387–393.

    Google Scholar 

  • Zheng, J., Thylin, M. R., Ghorpade, A., Xiong, H., Persidsky, Y., Cotter, R., Niemann, D., Che, M., Zeng, Y. C., Gelbard, H. A., Shepard, R. B., Swartz, J. M., & Gendelman, H. E. (1999). Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia. Journal of Neuroimmunology, 98(2), 185–200.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

Drs. Singer and Levine are supported by NINDS (NS-38841). Dr. Levine is also supported by the California HIV/AIDS Research Program (CHRP) Grant ID06-LA-187. Dr. Shapshak acknowledges support from NIH (GM056529, DA14533, and DA12580).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrew J. Levine.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Levine, A.J., Singer, E.J. & Shapshak, P. The Role of Host Genetics in the Susceptibility for HIV-associated Neurocognitive Disorders. AIDS Behav 13, 118–132 (2009). https://doi.org/10.1007/s10461-008-9360-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10461-008-9360-x

Keywords

Navigation